Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597069 | SCV000705337 | uncertain significance | not provided | 2018-03-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002532478 | SCV002978276 | uncertain significance | ALG3-congenital disorder of glycosylation | 2022-05-29 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs369888932, gnomAD 0.01%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 499704). This variant has not been reported in the literature in individuals affected with ALG3-related conditions. This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 5 of the ALG3 protein (p.Leu5Val). |